These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37277696)

  • 1. Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.
    Quddusi DM; Bajcinca N
    IET Syst Biol; 2023 Aug; 17(4):143-161. PubMed ID: 37277696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.
    Jiang Y; He J; Wang X; Liu C; Zhou W; Liu D; Guo Z; Liu K
    Platelets; 2023 Dec; 34(1):2212071. PubMed ID: 37212262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma.
    Sol N; In 't Veld SGJG; Vancura A; Tjerkstra M; Leurs C; Rustenburg F; Schellen P; Verschueren H; Post E; Zwaan K; Ramaker J; Wedekind LE; Tannous J; Ylstra B; Killestein J; Mateen F; Idema S; de Witt Hamer PC; Navis AC; Leenders WPJ; Hoeben A; Moraal B; Noske DP; Vandertop WP; Nilsson RJA; Tannous BA; Wesseling P; Reijneveld JC; Best MG; Wurdinger T
    Cell Rep Med; 2020 Oct; 1(7):100101. PubMed ID: 33103128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of lncRNA-TF crosstalks and identification of prognostic regulatory feedback loops of glioblastoma using lncRNA/TF-mediated ceRNA network.
    Ji Y; Gu Y; Hong S; Yu B; Zhang JH; Liu JN
    J Cell Biochem; 2020 Jan; 121(1):755-767. PubMed ID: 31478223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA as potential biomarkers in Glioblastoma.
    Areeb Z; Stylli SS; Koldej R; Ritchie DS; Siegal T; Morokoff AP; Kaye AH; Luwor RB
    J Neurooncol; 2015 Nov; 125(2):237-48. PubMed ID: 26391593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SAA1 as a prognostic biomarker associated with immune infiltration in glioblastoma.
    Cui G; Xiao Y
    Autoimmunity; 2022 Sep; 55(6):418-427. PubMed ID: 35574600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma.
    Rackles E; Lopez PH; Falcon-Perez JM
    Semin Cancer Biol; 2022 Dec; 87():148-159. PubMed ID: 36375777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway.
    Xu Y; Sun Q; Yuan F; Dong H; Zhang H; Geng R; Qi Y; Xiong X; Chen Q; Liu B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):174. PubMed ID: 32867814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma.
    Williams G; Llewelyn A; Thatcher R; Hardisty KM; Loddo M
    PLoS One; 2022; 17(3):e0245817. PubMed ID: 35324914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
    Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
    Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
    BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
    Skog J; Würdinger T; van Rijn S; Meijer DH; Gainche L; Sena-Esteves M; Curry WT; Carter BS; Krichevsky AM; Breakefield XO
    Nat Cell Biol; 2008 Dec; 10(12):1470-6. PubMed ID: 19011622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.
    Zhou P; Erfani S; Liu Z; Jia C; Chen Y; Xu B; Deng X; Alfáro JE; Chen L; Napier D; Lu M; Huang JA; Liu C; Thibault O; Segal R; Zhou BP; Kyprianou N; Horbinski C; Yang XH
    Oncotarget; 2015 Oct; 6(30):29675-93. PubMed ID: 26377974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biomarkers associated with extracellular vesicles based on an integrative pan-cancer bioinformatics analysis.
    Wang Q; Yu C
    Med Oncol; 2020 Aug; 37(9):79. PubMed ID: 32749536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.
    Fuentes-Fayos AC; Vázquez-Borrego MC; Jiménez-Vacas JM; Bejarano L; Pedraza-Arévalo S; L-López F; Blanco-Acevedo C; Sánchez-Sánchez R; Reyes O; Ventura S; Solivera J; Breunig JJ; Blasco MA; Gahete MD; Castaño JP; Luque RM
    Brain; 2020 Dec; 143(11):3273-3293. PubMed ID: 33141183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value.
    Zhou Y; Yang L; Zhang X; Chen R; Chen X; Tang W; Zhang M
    Biomed Res Int; 2019; 2019():6581576. PubMed ID: 31119182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis.
    Palande V; Siegal T; Detroja R; Gorohovski A; Glass R; Flueh C; Kanner AA; Laviv Y; Har-Nof S; Levy-Barda A; Viviana Karpuj M; Kurtz M; Perez S; Raviv Shay D; Frenkel-Morgenstern M
    Mol Oncol; 2022 May; 16(10):2098-2114. PubMed ID: 34875133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.